Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma

Circumscribed Choroidal Haemangioma Clinical Trial

Official title:
Safety and Effectiveness Study of Intravitreal Conbercept Injection for Exudative Circumscribed Choroidal Haemangioma

Status Recruiting

Clinical Trial Summary

This prospective clinical trial aims to evaluate the safety and effectiveness study of intravitreal conbercept injection for exudative circumscribed choroidal haemangioma.

Clinical Trial Description

This prospective clinical trial aims to evaluate the safety and effectiveness study of intravitreal conbercept injection for exudative circumscribed choroidal haemangioma: (1)To evaluate therapeutic effect (including both anatomical and functional responses to intravitreal conbercept injection) of intravitreal conbercept injectionfor exudative circumscribed choroidal haemangioma; (2)To evaluate the safety (including side effects of the eye as well as side effects of system) of intravitreal conbercept injection for exudative circumscribed choroidal haemangioma. ;

Study Design

Related Conditions & MeSH terms

Circumscribed Choroidal Haemangioma
Hemangioma

Clinical Trial Details

NCT number	NCT03571282
Study type	Interventional
Source	Sun Yat-sen University
Contact	Kunbei Lai, ph.D.
Phone	8602087331366
Email	laikb@163.com
Status	Recruiting
Phase	Early Phase 1
Start date	June 6, 2018
Completion date	June 6, 2019

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04449900` - Quantitative Evaluation of Parafoveal Microvasculature Changes in Eyes With Exudative Circumscribed Choroidal Haemangioma: An Optical Coherence Tomography Angiography Study
	Recruiting	`NCT03973125` - Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma	Early Phase 1